Bristol Gate Capital Partners’s CVS Health CVS Stock Holding History

Bristol Gate Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-298,998	Closed	-$26.6M	–	24
2016 Q3	$26.6M	Buy	298,998 +21,978	+8%	+$2.07M	4.58%	20
2016 Q2	$26.5M	Buy	277,020 +25,681	+10%	+$2.56M	4.74%	9
2016 Q1	$26.1M	Buy	251,339 +4,721	+2%	+$459K	4.82%	9
2015 Q4	$24.1M	Buy	246,618 +45,781	+23%	+$4.48M	4.69%	5
2015 Q3	$19.4M	Sell	200,837 -8,286	-4%	-$871K	4.42%	19
2015 Q2	$21.9M	Buy	209,123 +115,416	+123%	+$11.8M	4.76%	2
2015 Q1	$9.67M	Sell	93,707 -3,568	-4%	-$361K	5.28%	9
2014 Q4	$9.37M	Buy	+97,275	New	+$8.57M	4.94%	4

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bristol Gate Capital Partners's CVS Position: Q4 2016 in Review

Bristol Gate Capital Partners sold out of CVS Health (CVS) in Q4 2016, closing a stake of 298,998 shares — an estimated $26.6M sold.

Bristol Gate Capital Partners first reported a position in CVS in Q4 2014 and held it in 8 quarters. The position peaked at $26.6M in Q3 2016. 1,549 funds tracked by Wall St. Rank hold CVS as of Q4 2016.

Bristol Gate Capital Partners reported no remaining CVS Health position as of Q4 2016 after selling out during the quarter.
Bristol Gate Capital Partners sold 298,998 CVS Health shares in Q4 2016, an estimated $26.6M.
Bristol Gate Capital Partners first reported a position in CVS Health in Q4 2014 and held it in 8 quarters.
Bristol Gate Capital Partners's CVS Health position peaked at $26.6M in Q3 2016.
1,549 funds tracked by Wall St. Rank held CVS Health as of Q4 2016.

Based on Bristol Gate Capital Partners's 13F filing for Q4 2016, filed 8 Feb 2017.